We are live on ! Find out more
IP

Isthmus Partners Portfolio holdings

AUM $1.03B
1-Year Est. Return 22.86%
This Fund
S&P 500
This Quarter Est. Return
+11.79%
1 Year Est. Return
+22.86%
3 Year Est. Return
+61.07%
5 Year Est. Return
+76.25%
10 Year Est. Return
+352.5%
AUM
$666M
AUM Growth
+$84.7M
Cap. Flow
+$25.3M
Cap. Flow %
3.81%
Top 10 Hldgs %
28.14%
Holding
169
New
6
Increased
48
Reduced
69
Closed
4

Top Sells

Rank Stock Value
1
T icon
AT&T
T
+$5.78M
2
CI icon
Cigna
CI
+$5.62M
3
PYPL icon
PayPal
PYPL
+$3.4M
4
KSS icon
Kohl's
KSS
+$2.36M
5
DOC
PHYSICIANS REALTY TRUST
DOC
+$1.73M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 23.42%
2 Industrials 19.13%
3 Technology 13.63%
4 Healthcare 10.45%
5 Financials 9.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LGND icon
101
Ligand Pharmaceuticals
LGND
$6.07B
$1.32M 0.2%
19,830
-12,052
-38% -$784K
GSL icon
102
Global Ship Lease
GSL
$1.54B
$1.32M 0.2%
79,371
+2,041
+3% +$35.1K
OII icon
103
Oceaneering
OII
$4.83B
$1.31M 0.2%
74,766
-651
-0.9% -$8.65K
MTW icon
104
Manitowoc
MTW
$516M
$1.27M 0.19%
138,943
+4,678
+3% +$42.7K
MLKN icon
105
MillerKnoll
MLKN
$1.65B
$1.22M 0.18%
58,026
+4,934
+9% +$98.7K
NOG icon
106
Northern Oil and Gas
NOG
$2.17B
$1.17M 0.18%
37,922
-722
-2% -$24.3K
IXUS icon
107
iShares Core MSCI Total International Stock ETF
IXUS
$59.9B
$1.14M 0.17%
19,677
+1,635
+9% +$91.2K
BLFS icon
108
BioLife Solutions
BLFS
$1.63B
$1.1M 0.17%
60,545
+244
+0.4% +$5.04K
GMED icon
109
Globus Medical
GMED
$10.9B
$1.1M 0.17%
14,829
-15,948
-52% -$1.09M
MDXG icon
110
MiMedx Group
MDXG
$608M
$1.07M 0.16%
385,172
+26,064
+7% +$77.9K
GLD icon
111
SPDR Gold Trust
GLD
$138B
$1.02M 0.15%
6,000
EMBC icon
112
Embecta
EMBC
$211M
$1M 0.15%
39,704
-40
-0.1% -$1.22K
HY icon
113
Hyster-Yale Materials Handling
HY
$730M
$966K 0.15%
38,170
+1,919
+5% +$53.4K
XOM icon
114
ExxonMobil
XOM
$629B
$951K 0.14%
8,624
MATV icon
115
Mativ Holdings
MATV
$521M
$915K 0.14%
43,767
-488
-1% -$10.6K
UNP icon
116
Union Pacific
UNP
$175B
$830K 0.12%
4,008
CSL icon
117
Carlisle Companies
CSL
$15.3B
$798K 0.12%
3,386
-183
-5% -$47.1K
CULP icon
118
Culp Inc
CULP
$44.1M
$798K 0.12%
173,763
-1,365
-0.8% -$6.45K
INN
119
Summit Hotel Properties
INN
$742M
$790K 0.12%
109,443
+694
+0.6% +$5.43K
OABI icon
120
OmniAb
OABI
$299M
$691K 0.1%
+192,073
New +$1.01M
NEE icon
121
NextEra Energy
NEE
$179B
$676K 0.1%
8,087
IRIX icon
122
IRIDEX
IRIX
$14.7M
$671K 0.1%
333,792
+16,033
+5% +$35.6K
FAST icon
123
Fastenal
FAST
$57.2B
$622K 0.09%
26,288
G icon
124
Genpact
G
$5.96B
$576K 0.09%
12,441
USB icon
125
US Bancorp
USB
$100B
$566K 0.09%
12,983

Similar funds

Isthmus Partners's Q4 2022 Portfolio in Review

As of Q4 2022, Isthmus Partners held 169 positions worth $666M, up 15% from $581M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Isthmus Partners deployed $25.3M of net new capital in Q4 2022, opening 6 new positions and adding to 48 existing holdings. Its largest new stake was iShares Core MSCI EAFE ETF: 475,104 shares worth $29.3M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 23% of assets, down from 25% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Cigna, an estimated $5.62M trimmed.

  • Isthmus Partners's largest Q4 2022 buy was iShares Core MSCI EAFE ETF: 475,104 shares worth $29.3M.
  • Isthmus Partners added most to Gartner in Q4 2022, an estimated $6.8M increase.
  • Isthmus Partners's biggest Q4 2022 reduction was Cigna, cutting an estimated $5.62M.
  • Isthmus Partners fully exited AT&T in Q4 2022, selling an estimated $5.78M.
  • Isthmus Partners's ten largest holdings make up 28% of its $666M portfolio in Q4 2022.
  • Isthmus Partners opened 6 new positions and closed 4 in Q4 2022.
  • Isthmus Partners's portfolio value rose 15% quarter-over-quarter to $666M.

Based on Isthmus Partners's 13F filing for Q4 2022, filed 10 Feb 2023.